An investigation of the efficacy of surgical treatment in patients with cervical myelopathy

An investigation of the efficacy of surgical treatment in patients with cervical myelopathy - An investigation of the efficacy of surgical treatment in patients with cervical myelopathy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033500

Enrollment

150

Registered

2018-07-25

Start date

2007-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical myelopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cervical myelopathy

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follows: (1) history of cervical surgery; (2) history of cerebral palsy; (3) thoracic spondylotic myelopathy; (4) lumber disc herniation or lumber canal stenosis; (5) cervical radiculopathy; (6) rheumatoid arthritis; (7) destructive spondyloarthritis due to hemodialysis; (8) spinal cord tumor; (9) spinal cord injuries; (10) spinal fusion surgery.

Design outcomes

Primary

Measure	Time frame
Primary outcomes were the clinical evaluation and the image evaluation. We performed these assessments preoperatively and at 3, 6, 12, 18, and 24 months postoperatively.	—

Secondary

Measure	Time frame
1) the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) survey: preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 2)the 36-Item Short Form Health Survey (SF-36): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 3)Pain Vision PS-2100 (Nipro, Osaka, Japan) the current perception threshold (CPT): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively	—

Measure

Time frame

1) the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) survey: preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 2)the 36-Item Short Form Health Survey (SF-36): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 3)Pain Vision PS-2100 (Nipro, Osaka, Japan) the current perception threshold (CPT): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively

—

Countries

Japan

Contacts

Public ContactTakeshi Inoue

The Jikei University Katsushika Medical Center Department of Orthopaedic Surgery

inoue@jikei.ac.jp03-3603-2111

Outcome results